| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2002;39:903.)
© 2002 American Heart Association, Inc.
Scientific Contributions |
From the Department of Pediatrics, University of Texas-Houston Medical School.
Correspondence to Jonathan M. Sorof, MD, Associate Professor, Division of Pediatric Nephrology and Hypertension, University of Texas-Houston, Medical School, 6431 Fannin St, Room 3.124, Houston, TX 77030. E-mail jonathan.m.sorof{at}uth.tmc.edu
| Abstract |
|---|
|
|
|---|
Key Words: children blood pressure monitoring, ambulatory hypertrophy, left ventricular cardiovascular disease risk factors
| Introduction |
|---|
|
|
|---|
In hypertensive adults, ambulatory blood pressure parameters are reported to be better correlated with LVMI and more predictive of LVH than are casual blood pressure values.1527 Although a previous study of mildly hypertensive children confirmed that ambulatory blood pressure is better correlated with LVMI than is casual blood pressure, neither casual nor ambulatory blood pressure values differentiated patients with and without LVH.14 To determine the ambulatory blood pressure monitoring (ABPM) variables most closely associated with LVMI and/or predictive of the presence of LVH in hypertensive children, echocardiography and ABPM data from children referred to a pediatric hypertension clinic for evaluation were analyzed.
| Methods |
|---|
|
|
|---|
3 months apart, no known secondary causes of hypertension, and no antihypertensive medications during ABPM. A comparison group of normotensive children who had echocardiography during the same period for other indications was identified. Inclusion criteria were technically adequate m-mode measurements for LVMI calculation, no history of elevated blood pressure, no previously documented structural cardiac abnormalities, and no current abnormalities other than trivial tricuspid or mitral regurgitation. Indications for echocardiography in the normotensive group included syncope, chest pain, murmurs, arrhythmias, and rule-out of coronary artery aneurysms secondary to Kawasakis disease. The study was approved by an institutional review committee. Left ventricular mass (LVM) was calculated from 2D-guided m-mode echocardiographic measurements of the left ventricle. Measurements of the left ventricle internal dimension, interventricular septal thickness, and posterior wall thickness were made during diastole according to methods established by the American Society of Echocardiography. LVM was calculated using the Devereux equation.28 LVMI was calculated by dividing LVM by height2.7 to minimize effects of age, gender, ethnicity, and overweight status.29,30 LVH was defined as LVMI >51 g/m2.7, a value greater than the pediatric 99th percentile that is associated with a 4.1-fold risk of cardiovascular morbidity in hypertensive adults.31
ABPM was performed as previously described.32 ABPM data were analyzed by calculating average blood pressure, blood pressure load, and blood pressure index for the entire 24-hour period, wake period, and sleep period. Average blood pressure was calculated by averaging the blood pressure values during the monitoring period. Blood pressure load was calculated as the percentage of each patients blood pressure values that exceeded the pediatric ambulatory 95th percentile blood pressure specific for that patient (derived from a study of ABPM values from 1141 healthy children33). Blood pressure index was calculated by dividing the average blood pressure for each patient by the 95th percentile blood pressure value specific for that patient. Calculated in this manner, a blood pressure index of 1.1 would correspond to blood pressure that was 10% above the 95th percentile, and thus provides an index of the relative severity of blood pressure elevation.32 In addition, blood pressure dipping was calculated by subtracting the average sleep blood pressure from the average wake and dividing the sum by the average wake blood pressure.
Descriptive statistics are presented as percentages, means, and SDs. Univariate analyses for group comparisons of continuous variables were performed using Students t test. Multivariate analyses for group comparisons were performed using ANOVA. The correlation between LVMI and continuous demographic, clinical, and hemodynamic variables was determined using the Pearson correlation coefficient. Multiple regression analysis was used to determine the strength of association between LVMI and multiple independent variables. Fishers exact test was used to compare the LVH percentage between groups. P>0.05 indicated statistical significance.
| Results |
|---|
|
|
|---|
|
The association between echocardiographic and ABPM variables was determined by univariate and multivariate analyses. LVMI showed the strongest correlation with ambulatory SBP index (r=0.43, P=0.008) (Figure) among all demographic and clinical variables analyzed. LVMI also showed significant correlations with 24-hour SBP (r=0.34, P=0.037), 24-hour SBP load (r=0.38, P=0.020), wake SBP load (r=0.37, P=0.025), sleep SBP (r=0.33, P=0.048), and sleep SBP load (r=0.38, P=0.021). LVMI did not correlate significantly with age, weight, clinic blood pressure, clinic blood pressure index, or any ambulatory diastolic blood pressure parameters. Interventricular septal thickness showed significant univariate correlations with 24-hour SBP (r=0.43, P=0.008), wake SBP (r=0.44, P=0.007), and sleep SBP (r=0.39, P=0.017). Similarly, left ventricular posterior wall thickness showed significant univariate correlations with 24-hour SBP (r=0.41, P=0.012), wake SBP (r=0.39, P=0.016), and sleep SBP (0.41, P=0.012). Both septal thickness and posterior wall thickness also showed significant univariate correlations with age and weight. Multiple regression analysis controlling for age and weight showed significant correlations between septal thickness and 24-hour SBP (P=0.04) and between septal thickness and wake SBP (P=0.04).
|
Comparisons of demographic and clinical data between patients with and without LVH are shown in Table 2. Patients with and without LVH did not differ in age, gender distribution, height, weight, or body mass index. Patients with LVH had significantly higher 24-hour SBP (P=0.035), sleep SBP (P=0.024), and ambulatory SBP index (P=0.022) compared with those values in patients without LVH and tended to have higher 24-hour SBP load (P=0.080), wake SBP (P=0.058), wake SBP load (P=0.077), and sleep SBP load (P=0.050). Patients with and without LVH did not differ in clinic blood pressure or in any diastolic hemodynamic parameters.
|
The prediction of LVH by ABPM parameters was assessed by defining threshold values for blood pressure load and blood pressure index. A higher prevalence of LVH was found when SBP load was >50% (P=0.038) or when ambulatory SBP index was >1.0 (P=0.024). When both SBP load was >50% and ambulatory SBP index was >1.0, the prevalence of LVH was 47% (8 of 17). When both criteria were not met, the prevalence of LVH was 10% (2 of 20, P=0.015). The sensitivity and specificity for this combination of ABPM criteria for predicting LVH were 80% and 67%, respectively.
| Discussion |
|---|
|
|
|---|
The results from the current study are consistent with those of previous studies that show positive associations between ambulatory SBP parameters and LVMI in hypertensive children.14,38 In separate studies of children and young adults with mild blood pressure elevation, LVMI was reported to be positively correlated with ambulatory wake SBP38 and with 24-hour, wake, and sleep SBP.14 Consistent with these previous studies, the current study found that only ambulatory SBP parameters, and not diastolic blood pressure parameters, were correlated with LVMI. Studies of hypertensive adults have found that blood pressure load is more closely associated with cardiac function than mean blood pressure.24 The current study showed that ambulatory blood pressure index (a measure of relative ambulatory hypertension severity) was more strongly associated with LVMI than casual blood pressure, mean ambulatory blood pressure, or blood pressure load. This finding suggests that ambulatory blood pressure index may be a more robust indicator of the severity of blood pressure elevation over a 24-hour period than is blood pressure load, which describes only the percentage of blood pressure values that are abnormal.
The prevalence of LVH in the current study was 27% in the hypertensive group using the restrictive LVH definition of LVMI >51 g/m2.7. The absence of LVH in any patient in the normotensive comparison group from the same center provides validation of this relatively high prevalence of LVH in the hypertensive group. Previous studies have reported a prevalence of LVH in hypertensive children that ranges from 10% to 38%,614 depending in part on the method of indexing LVM and the criteria used to define pathologically increased LVMI. In the current study, LVM was calculated by the formula of Devereux28 and indexed to height to the power of 2.7. This approach to indexing is reported to have a high correlation with LVM/lean body mass and minimizes the effect of overweight status on LVMI.29,30 The threshold of 51 g/m2.7 to define LVH corresponds to an LVMI greater than the pediatric 99th percentile (ie, severe LVH)39 and is reported to be associated with a 4-fold higher risk for the development of cardiovascular endpoints in hypertensive adults.31 The only previous study reporting the prevalence of LVMI >51 g/m2.7 in hypertensive children found that 8% to 9% of patients (11 of 130) exceeded this threshold.39 This discrepancy may be because the patients in the current study had evidence of more severe hypertension as shown by higher mean clinic SBP values (138.7 versus 135.4 mm Hg), despite being younger (13.5 versus 14.7 years) and shorter (161 versus 166 cm) than patients in the previous study.
The current study clearly demonstrates hypertensive children with LVH have higher ambulatory blood pressure parameters compared with those of children without LVH. These differences persisted even after controlling for age, gender, and weight. In contrast, no differences were found in clinic blood pressure values. These results differ from those of a previous study of mildly hypertensive children in which no differences in ambulatory SBP parameters and lower ambulatory diastolic blood pressure were found in patients with LVH compared with those without LVH.14 Previous studies of hypertensive adults have reported that 90% of hypertensive adults with a SBP load >50% had LVH compared with <10% of patients with a SBP load <30%.40 In the current study, the combined criteria of SBP load threshold of 50% and ambulatory SBP index threshold of 1.0 showed a sensitivity and specificity for LVH of 80% and 67%, respectively. These data suggest that ABPM may predict the presence of LVH in hypertensive children, as has been demonstrated in hypertensive adults.
The current study is limited by several factors. Although the current study is one of the largest to date in children, greater numbers of normotensive and hypertensive patients undergoing both ABPM and echocardiography are needed before the results may be generalized to the overall pediatric population or to the at-risk population of hypertensive children. In addition, there may have been selection bias toward referral of patients to the clinic with more severe or long-standing blood pressure elevation. Thus, the prevalence of LVH in hypertensive children in general is likely to be lower than in this referral-based population. Because the primary aim of the current study was to determine the ambulatory blood pressure parameters that are most closely related to LVMI and predictive of LVH, the study of a more severely affected population of children with an anticipated higher prevalence of LVH is appropriate as an initial approach to the question. Finally, the majority of patients in the current study had systolic hypertension, which may have biased the study results to show a stronger association between SBP and LVMI. However, previous studies have found that the majority of hypertensive children have systolic hypertension, with diastolic hypertension occurring less commonly.41
| Perspectives |
|---|
|
|
|---|
| Acknowledgments |
|---|
Received December 17, 2001; first decision January 17, 2002; accepted February 6, 2002.
| References |
|---|
|
|
|---|
2.
Malcolm DD, Burns TL, Mahoney LT, Lauer RM. Factors affecting left ventricular mass in childhood: the Muscatine Study. Pediatrics. 1993; 92: 703709.
3.
Daniels SR, Kimball TR, Morrison JA, Khoury P, Witt S, Meyer RA. Effect of lean body mass, fat mass, blood pressure, and sexual maturation on left ventricular mass in children and adolescents: statistical, biological, and clinical significance. Circulation. 1995; 92: 32493254.
4. Treiber FA, McCaffrey F, Pflieger K, Raunikar RA, Strong WB, Davis H. Determinants of left ventricular mass in normotensive children. Am J Hypertens. 1993; 6: 505513.[Medline] [Order article via Infotrieve]
5.
Harshfield GA, Koelsch DW, Pulliam DA, Alpert BS, Richey PA, Becker JA. Racial differences in the age-related increase in left ventricular mass in youths. Hypertension. 1994; 24: 747751.
6.
Laird WP, Fixler DE. Left ventricular hypertrophy in adolescents with elevated blood pressure: assessment by chest roentgenography, electrocardiography, and echocardiography. Pediatrics. 1981; 67: 255259.
7.
Culpepper WS, Sodt PC, Messerli FH, Ruschhaupt DG, Arcilla RA. Cardiac status in juvenile borderline hypertension. Ann Intern Med. 1983; 98: 17.
8.
Daniels SR, Meyer RA, Loggie JM. Determinants of cardiac involvement in children and adolescents with essential hypertension. Circulation. 1990; 82: 12431248.
9. Goldring D, Hernandez A, Choi S, Lee JY, Londe S, Lindgren FT, Burton RM. Blood pressure in a high school population, II: clinical profile of the juvenile hypertensive. J Pediatr. 1979; 95: 298304.[CrossRef][Medline] [Order article via Infotrieve]
10. Culpepper WS. Cardiac anatomy and function in juvenile hypertension: current understanding and future concerns. Am J Med. 1983; 75: 5761.[Medline] [Order article via Infotrieve]
11.
Schieken RM, Clarke WR, Lauer RM. Left ventricular hypertrophy in children with blood pressures in the upper quintile of the distribution: the Muscatine Study. Hypertension. 1981; 3: 669675.
12. Richter R. Echokardiographische Untersuchungen von Kindern und Jugendlichen mit primarer Hypertonie. Kinderarztl Prax. 1993; 61: 279284.[Medline] [Order article via Infotrieve]
13. Johnson MC, Bergersen LJ, Beck A, Dick G, Cole BR. Diastolic function and tachycardia in hypertensive children. Am J Hypertens. 1999; 12: 10091014.[CrossRef][Medline] [Order article via Infotrieve]
14. Belsha CW, Wells TG, McNiece KL, Seib PM, Plummer JK, Berry PL. Influence of diurnal blood pressure variations on target organ abnormalities in adolescents with mild essential hypertension. Am J Hypertens. 1998; 11: 410417.[CrossRef][Medline] [Order article via Infotrieve]
15. Mansoor GA, White WB. Contribution of ambulatory blood pressure monitoring to the design and analysis of antihypertensive therapy trials. J Cardiovasc Risk. 1994; 1: 136142.[Medline] [Order article via Infotrieve]
16. Staessen JA, OBrien ET, Amery AK, Atkins N, Baumgart P, De Cort P, Degaute JP, Dolenc P, De Gaudemaris R, Enstrom I. Ambulatory blood pressure in normotensive and hypertensive subjects: results from an international database. J Hypertens. 1994; 12 (suppl): S1S12.
17. Modesti PA, Pieri F, Cecioni I, Valenti R, Mininni S, Toccafondi S, Vocioni F, Salvati G, Gensini GF, Neri Serneri GG. Comparison of ambulatory blood pressure monitoring and conventional office measurement in the workers of a chemical company. Int J Cardiol. 1994; 46: 151157.[CrossRef][Medline] [Order article via Infotrieve]
18. Mancia G, Frattola A, Groppelli A, Omboni S, Parati G, Ulian L, Villani A. Blood pressure reduction and end-organ damage in hypertension. J Hypertens. 1994; 12 (suppl): S35S41.
19. Siche JP, Schwebel C, Longere P, Tremel F, De Gaudemaris R, Comparat V, Mallion JM. Hypertrophie ventriculaire gauche et variabilite de la pression arterielle au repos et en ambulatoire chez lhypertendu. Arch Mal Coeur Vaiss. 1994; 87: 10051009.[Medline] [Order article via Infotrieve]
20. Pai PY, Chou HT, Tsou SS, Wang TF. The prognostic value of ambulatory blood pressure monitoring in untreated mild-to-moderate hypertensive patients: correlation with echocardiography. Chung Hua I Hsueh Tsa Chih (Taipei). 1994; 54: 9399.
21. Perloff D, Sokolow M, Cowan RM, Juster RP. Prognostic value of ambulatory blood pressure measurements: further analyses. J Hypertens. 1989; 7 (suppl): S3S10.[CrossRef]
22.
Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, Porcellati C. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation. 1990; 81: 528536.
23.
White WB, Schulman P, McCabe EJ, Dey HM. Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. JAMA. 1989; 261: 873877.
24. White WB, Dey HM, Schulman P. Assessment of the daily blood pressure load as a determinant of cardiac function in patients with mild-to-moderate hypertension. Am Heart J. 1989; 118: 782795.[CrossRef][Medline] [Order article via Infotrieve]
25. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens. 1987; 5: 9398.[CrossRef][Medline] [Order article via Infotrieve]
26. Antonicelli R, Partemi M, Spazzafumo L, Amadio L, Paciaroni E. Blood pressure self-measurement in the elderly: differences between automatic and semi-automatic systems. J Hum Hypertens. 1995; 9: 229231.[Medline] [Order article via Infotrieve]
27.
Redon J, Campos C, Narciso ML, Rodicio JL, Pascual JM, Ruilope LM. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension. 1998; 31: 712718.
28. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986; 57: 450458.[CrossRef][Medline] [Order article via Infotrieve]
29. Daniels SR, Kimball TR, Morrison JA, Khoury P, Meyer RA. Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiovascular disease. Am J Cardiol. 1995; 76: 699701.[CrossRef][Medline] [Order article via Infotrieve]
30. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, Alderman MH. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol. 1992; 20: 12511260.[Abstract]
31. de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol. 1995; 25: 10561062.[Abstract]
32. Sorof JM, Poffenbarger T, Franco K, Portman R. Evaluation of white coat hypertension in children: importance of the definitions of normal ambulatory blood pressure and the severity of casual hypertension. Am J Hypertens. 2001; 14: 855860.[CrossRef][Medline] [Order article via Infotrieve]
33. Soergel M, Kirschstein M, Busch C, Danne T, Gellermann J, Holl R, Krull F, Reichert H, Reusz GS, Rascher W. Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr. 1997; 130: 178184.[CrossRef][Medline] [Order article via Infotrieve]
34.
Fixler DE, Laird WP, Fitzgerald V, Stead S, Adams R. Hypertension screening in schools: results of the Dallas study. Pediatrics. 1979; 63: 3236.
35. Sinaiko AR, Gomez-Marin O, Prineas RJ. Prevalence of "significant" hypertension in junior high school-aged children: the Children and Adolescent Blood Pressure Program. J Pediatr. 1989; 114: 664669.[CrossRef][Medline] [Order article via Infotrieve]
36. Berenson GS, Shear CL, Chiang YK, Webber LS, Voors AW. Combined low-dose medication and primary intervention over a 30-month period for sustained high blood pressure in childhood. Am J Med Sci. 1990; 299: 7986.[Medline] [Order article via Infotrieve]
37. Sorof JM, Cargo P, Graepel J, King E, Rolf C, Humphrey D, Cunningham RJ, The Ziac Pediatric Hypertension Study Group. ß-Blocker/thiazide combination for treatment of hypertensive children: a randomized, double-blind, placebo-controlled trial. Pediatr Nephrol. In press.
38. Chamontin B, Amar J, Barthe P, Salvador M. Blood pressure measurements and left ventricular mass in young adults with arterial hypertension screened at high school check-up. J Hum Hypertens. 1994; 8: 357361.[Medline] [Order article via Infotrieve]
39.
Daniels SR, Loggie JM, Khoury P, Kimball TR. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation. 1998; 97: 19071911.
40. White WB. Hypertensive target organ involvement and 24-hour ambulatory blood pressure measurement.In: Waeber B, OBrien E, OMalley K, Brunner H, eds. Ambulatory Blood Pressure Monitoring. New York: Raven, 1994: 4760.
41. Sorof JM. Systolic hypertension in children: benign or beware? Pediatr Nephrol. 2001; 16: 517525.[CrossRef][Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
A. M Franks, C. E O'Brien, C. D Stowe, T. G Wells, and S. F Gardner Candesartan Cilexetil Effectively Reduces Blood Pressure in Hypertensive Children Ann. Pharmacother., October 1, 2008; 42(10): 1388 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Urbina, B. Alpert, J. Flynn, L. Hayman, G. A. Harshfield, M. Jacobson, L. Mahoney, B. McCrindle, M. Mietus-Snyder, J. Steinberger, et al. Ambulatory Blood Pressure Monitoring in Children and Adolescents: Recommendations for Standard Assessment: A Scientific Statement From the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young and the Council for High Blood Pressure Research Hypertension, September 1, 2008; 52(3): 433 - 451. [Full Text] [PDF] |
||||
![]() |
B. J. Foster, A. S. Mackie, M. Mitsnefes, H. Ali, S. Mamber, and S. D. Colan A Novel Method of Expressing Left Ventricular Mass Relative to Body Size in Children Circulation, May 27, 2008; 117(21): 2769 - 2775. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. McNiece, M. Gupta-Malhotra, J. Samuels, C. Bell, K. Garcia, T. Poffenbarger, J. M. Sorof, and R. J. Portman Left Ventricular Hypertrophy in Hypertensive Adolescents: Analysis of Risk by 2004 National High Blood Pressure Education Program Working Group Staging Criteria Hypertension, August 1, 2007; 50(2): 392 - 395. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mitchell, N. Cheung, K. de Haseth, B. Taylor, E. Rochtchina, F. M. A. Islam, J. J. Wang, S. M. Saw, and T. Y. Wong Blood Pressure and Retinal Arteriolar Narrowing in Children Hypertension, May 1, 2007; 49(5): 1156 - 1162. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Lande, N. L. Carson, J. Roy, and C. C. Meagher Effects of Childhood Primary Hypertension on Carotid Intima Media Thickness: A Matched Controlled Study Hypertension, July 1, 2006; 48(1): 40 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Mitsnefes, T. R. Kimball, S. A. Witt, B. J. Glascock, P. R. Khoury, and S. R. Daniels Abnormal Carotid Artery Structure and Function in Children and Adolescents With Successful Renal Transplantation Circulation, July 6, 2004; 110(1): 97 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hanevold, J. Waller, S. Daniels, R. Portman, and J. Sorof The Effects of Obesity, Gender, and Ethnic Group on Left Ventricular Hypertrophy and Geometry in Hypertensive Children: A Collaborative Study of the International Pediatric Hypertension Association Pediatrics, February 1, 2004; 113(2): 328 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Sorof, J. Turner, D. S. Martin, K. Garcia, Z. Garami, A. V. Alexandrov, F. Wan, and R. J. Portman Cardiovascular Risk Factors and Sequelae in Hypertensive Children Identified by Referral Versus School-Based Screening Hypertension, February 1, 2004; 43(2): 214 - 218. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Flynn Ethics of Placebo Use in Pediatric Clinical Trials: The Case of Antihypertensive Drug Studies Hypertension, November 1, 2003; 42(5): 865 - 869. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |